Therapeutic vaccine efficacy was associated with improved CD8+ TIL content, with these T cells producing IFN-γ in response to in vitro stimulation with tumor cells or flow-sorted populations of tumor-associated PVECs, but not model-irrelevant EL4 thymoma cells. The gene discussed is CD8A; the disease is thymoma.